Zacks Research Has Pessimistic Outlook of Biogen Q2 Earnings
Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities researchers at Zacks Research cut their Q2 2025 earnings per share estimates for Biogen in a report issued on Thursday, May 15th. Zacks Research analyst S. Ganoria now anticipates that the biotechnology company will post earnings of $4.09 per share for the quarter, down from their prior […]
Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities researchers at Zacks Research cut their Q2 2025 earnings per share estimates for Biogen in a report issued on Thursday, May 15th. Zacks Research analyst S. Ganoria now anticipates that the biotechnology company will post earnings of $4.09 per share for the quarter, down from their prior […]
